Month: April 2015

Thai – Japan joint venture on regenerative medicine: clinical trials proceed in Thailand

Based on technology for knee cartilage repair developed at Mukogawa Women’s University and on equipment for tissue expansion developed by Kawasaki Heavy Industries under a NEDO contract, the first clinical trials were now done at Chulalongkorn University and Srinakhanrinwirot University, Bangkok. This venture is important to Japan for developing ASEAN markets for her regenerative medicine […]

Evergene and Stagen start jointly into genetic analysis business

Evergene, a 100 % subidiary of e-service provider MIT, and Stagen, a Tokyo-based service provider for clinical tests, have started their genetic analysis business „DearGene“. The focus is on genetic risk prediction of various life-style related diseases, female health management, food allergy and cancer. SNP analysis is handled by Takara Bio Evergene press release, April […]

Japan Vaccine obtains approval for intradermal application of seasonal flu vaccine

Japan Vaccine, a joint venture of several companies including Daiichi Sankyo and Terumo, has obtained manufacturing and sales permission for a device developed by Terumo that combines a needle and pre-filled syringe for the administration of Kitasato Daiichi Sankyo influenza HA vaccine into the upper parts of skin. This is believed to improve recognition by […]

JST forms Adipo Medical Technology Co., a „pre-venture“ for the treatment of severe heart failure using regenerative cell technology

The treatment uses adipose tissue-derived multipotent progenitor cells as a raw material, which are changed into cardiomyocytes within the heart muscle after administration by a cardiac catheter. Whereas the competing technology of cell sheets requires cardiovascular surgery, over 1200 hospitals in Japan can perform heart catheterization, and treatment can be done in a hospital at […]

Researchers at RIKEN and the University of Tokyo elucidate the structure oft wo adiponectin receptors, relevance for obesity and diabetes research

Using RIKEN’s SPring-8 synchrotron facility, the structures of AdipoR1 and AdipoR2, two human adiponectin receptors, were solved. It is hoped that this study will contribute to the development of new adiponectin receptor agonists that can be used for the treatment of obesity-related diseases such as type 2 diabetes. Hiroaki TANABE et al., Nature, doi: 10.1038/nature14301

RIKEN starts up new supercomputer system „HOKUSAI GreatWave“

HOKUSAI-GW is the follower oft he RIKEN super Combined Cluster RSCC, operating since 2004, and the RIKEN Integrated Cluster of Clusters RICC, established 2009. The massively parallel computing system performs up to 1000 trillion floating point operations per second and will service RIKEN’s physics, chemistry, biology, and medical science departments. The HOKUSAI-GW system aims towards […]

Scroll to top